Tissue-specific_JJ
activity_NN
of_IN
the_DT
gammac_NN
chain_NN
gene_NN
promoter_NN
depends_VBZ
upon_IN
an_DT
Ets_NN
binding_NN
site_NN
and_CC
is_VBZ
regulated_VBN
by_IN
GA-binding_JJ
protein_NN
._.

The_DT
gammac_NN
chain_NN
is_VBZ
a_DT
subunit_NN
of_IN
multiple_JJ
cytokine_NN
receptors_NNS
-LRB-_-LRB-
interleukin_NN
-LRB-_-LRB-
IL_NN
-RRB-_-RRB-
-2_CD
,_,
IL-4_NN
,_,
IL-7_NN
,_,
IL-9_NN
,_,
and_CC
IL-15_NN
-RRB-_-RRB-
,_,
the_DT
expression_NN
of_IN
which_WDT
is_VBZ
restricted_JJ
to_TO
hematopoietic_JJ
lineages_NNS
._.

A_DT
defect_NN
in_IN
gammac_NN
leads_VBZ
to_TO
the_DT
X-linked_JJ
severe_JJ
combined_JJ
immunodeficiency_NN
characterized_VBN
by_IN
a_DT
block_NN
in_IN
T_NN
cell_NN
differentiation_NN
._.

In_IN
order_NN
to_TO
better_RBR
characterize_VB
the_DT
human_JJ
gammac_NN
promoter_NN
and_CC
define_VB
the_DT
minimal_JJ
tissue-specific_JJ
promoter_NN
region_NN
,_,
progressive_JJ
5_CD
'_NN
-_:
deletion_NN
constructs_NNS
of_IN
a_DT
segment_NN
extending_VBG
1053_CD
base_NN
pairs_NNS
upstream_RB
of_IN
the_DT
major_JJ
transcription_NN
start_NN
site_NN
were_VBD
generated_VBN
and_CC
tested_VBN
for_IN
promoter_NN
activity_NN
in_IN
various_JJ
hematopoietic_JJ
and_CC
nonhematopoietic_JJ
cell_NN
types_NNS
._.

The_DT
-1053_CD
\/_:
+34_CD
construct_NN
allowed_VBD
promoter_NN
activity_NN
only_RB
in_IN
cells_NNS
of_IN
hematopoietic_JJ
origin_NN
,_,
and_CC
tissue_NN
specificity_NN
was_VBD
conserved_VBN
in_IN
all_DT
other_JJ
constructs_NNS
tested_VBN
._.

The_DT
region_NN
downstream_JJ
of_IN
-90_CD
appeared_VBD
critical_JJ
for_IN
basal_JJ
promoter_NN
activity_NN
._.

It_PRP
contains_VBZ
two_CD
potential_JJ
Ets_NN
binding_NN
sites_NNS
conserved_VBN
in_IN
the_DT
murine_JJ
gammac_NN
promoter_NN
gene_NN
,_,
one_CD
of_IN
which_WDT
was_VBD
found_VBN
essential_JJ
for_IN
functional_JJ
promoter_NN
activity_NN
as_IN
determined_VBN
by_IN
mutational_JJ
analysis_NN
._.

The_DT
functional_JJ
Ets_NN
binding_NN
site_NN
was_VBD
found_VBN
to_TO
bind_VB
Ets_NN
family_NN
proteins_NNS
,_,
principally_RB
GA-binding_JJ
protein_NN
and_CC
Elf-1_NN
and_CC
could_MD
be_VB
transactivated_VBN
by_IN
GABPalpha_NN
and_CC
-_JJ
beta_NN
synergistically_RB
._.

These_DT
results_NNS
indicate_VBP
that_IN
,_,
as_IN
already_RB
reported_VBN
for_IN
the_DT
IL2Rbeta_NN
promoter_NN
,_,
GA-binding_JJ
protein_NN
is_VBZ
an_DT
essential_JJ
component_NN
of_IN
gammac_NN
basal_JJ
promoter_NN
activity_NN
._.

Although_IN
GABP_NN
expression_NN
is_VBZ
not_RB
restricted_JJ
to_TO
the_DT
hematopoietic_JJ
lineage_NN
,_,
its_PRP$
interaction_NN
with_IN
other_JJ
specific_JJ
factors_NNS
may_MD
contribute_VB
to_TO
the_DT
tissue-specific_JJ
expression_NN
of_IN
the_DT
gammac_NN
gene_NN
._.

